(Q24247994)

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Chronic tension headache--treated with amitriptyline--a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

A Clinical Evaluation of Depressives Found in a Rural Survey in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Amitriptyline in Anxious-Depressed Outpatients: A Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

The effect of low dose lofepramine in depressed elderly patients in general medical wards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

The Nottingham study of neurotic disorder: comparison of drug and psychological treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

A Double Blind Trial for the Clinical Management of Psychogenic Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

How study design affects outcomes in comparisons of therapy. I: Medical

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Treatment, outcome and predictors of response in elderly depressed in-patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Recognition and management of depression in general practice: consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Outpatient utilization of antidepressants: a prescription database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Patterns of antidepressant use in community practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

Doxepin: Is a Single Daily Dose Enough?

21 January 2018

1 reference

12 December 2020

The Hampshire Depression Project: development and piloting of clinical practice guidelines and education about depression in primary health care

1 reference

12 December 2020

Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness

1 reference

12 December 2020

[Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo]

1 reference

12 December 2020

The undertreatment of depression

1 reference

12 December 2020

The treatment of depression: prescribing patterns of antidepressants in primary care in the UK

1 reference

12 December 2020

The analgesic effect of amitriptyline on chronic facial pain

1 reference

12 December 2020

Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group

1 reference

12 December 2020

Tofranil in the treatment of low back pain

1 reference

12 December 2020

The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms.

1 reference

12 December 2020

Two dosages of imipramine in hospitalized endogenous and neurotic depressives

1 reference

12 December 2020

Cianopramine and amitriptyline in the treatment of depressed patients--a placebo-controlled study

1 reference

12 December 2020

Antidepressant treatment of depression: a metaanalysis

1 reference

12 December 2020

Trazodone in the treatment of neurotic depression

1 reference

12 December 2020

Mianserin in the treatment of depression in general practice

1 reference

12 December 2020

Buspirone and imipramine for the treatment of major depression in the elderly

1 reference

12 December 2020

Imipramine in alopecia areata. A double-blind, placebo-controlled study

1 reference

12 December 2020

The treatment of depression in patients with epilepsy. A double-blind trial

1 reference

12 December 2020

Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG)

1 reference

12 December 2020

Prescribing antidepressants in general practice. More on what is an effective dose

1 reference

12 December 2020

[Controlled study of treatment of residual depression by clomipramine versus placebo]

1 reference

12 December 2020

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

1 reference

12 December 2020

Doctor-patient concordance in a placebo-controlled trial of limbitrol versus its components [proceedings]

1 reference

12 December 2020

Drug treatment in depressive illness

1 reference

12 December 2020

Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease

1 reference

12 December 2020

The Use of Doxepin in the Treatment of Symptoms of Anxiety Neurosis and Accompanying Depression: A Collaborative Controlled Study

1 reference

12 December 2020

A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly

1 reference

12 December 2020

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association

1 reference

12 December 2020

Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression

1 reference

12 December 2020

Differential drug effects in neurotic depression

1 reference

12 December 2020

Mianserin in the treatment of depressive illness and anxiety states in general practice

1 reference

12 December 2020

Dose effects of antidepressant medication in different populations. A World Health Organization Collaborative Study

1 reference

12 December 2020

Clomipramine in the prevention of migraine

1 reference

12 December 2020

Treatment received by depressed patients

1 reference

12 December 2020

A trial of imipramine (Tofranil) in depressed patients with chronic physical disease

1 reference

12 December 2020

Amytriptyline and chlordiazepoxide (Limbitrol) in depressive states in Nigerians--a double-blind study.

1 reference

12 December 2020

Amitriptyline for Depressed Women with Young Children in General Practice

1 reference

12 December 2020

A treatment outline for depressive disorders. The Quality Assurance Project

1 reference

12 December 2020

Amitriptyline in emotional states at the menopause

1 reference

12 December 2020

Plasma levels and therapeutic response with trimipramine treatment of endogenous depression.

1 reference

12 December 2020

Effects of amitriptyline on depressive and anxiety states in penitentiary inmates

1 reference

12 December 2020

Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study

1 reference

12 December 2020

[Double-blind clinical study with a new psychotropic agent: doxepin versus placebo]

1 reference

12 December 2020

Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial

1 reference

12 December 2020

A double blind controlled clinical trial of benzoctamin (Tacitin) and imipramine (Tofranil) in the treatment of 'internal heat' and its association symptoms.

1 reference

12 December 2020

Treatment Received by Depressed Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003197

7 January 2021